The Beauty Health Company (NASDAQ:SKIN) Q1 2022 Results Conference Call May 10, 2022 4:30 PM ET
Company Participants
Eduardo Rodriguez - Senior Director of M&A and Investor Relations
Andrew Stanleick - President & Chief Executive Officer
Liyuan Woo - Chief Financial Officer
Conference Call Participants
Steph Wissink - Jefferies
Oliver Chen - Cowen
Allen Gong - JPMorgan
Margaret Kaczor - William Blair
Jon Block - Stifel
Olivia Tong - Raymond James
Bruce Jackson - The Benchmark Company
Korinne Wolfmeyer - Piper Sandler
Linda Bolton-Weiser - DA Davidson
Operator
Good afternoon, and welcome to the Beauty Health First Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Eduardo Rodriguez, Senior Director of M&A and Investor Relations. Please go ahead.
Eduardo Rodriguez
Good afternoon, everyone. Thank you for joining the Beauty Health Company's conference call to discuss the Company's first quarter 2022 financial results, which we released this afternoon and can be found on our website at beautyhealth.com. Also available on our website is an investor presentation that will be referenced during this call. With me on the call today is Andrew Stanleick, President and Chief Executive Officer; and Liyuan Woo, Chief Financial Officer of the Beauty Health Company.
Before we get started, I would like to remind you of the Company's safe harbor language. Management may make forward-looking statements, including guidance and underlying assumptions. Forward-looking statements are based on expectations that involve risks and uncertainties that could cause actual results to differ materially. For a further discussion of risks related to our business, see our filings with the SEC.
This call will contain non-GAAP financial measures, such as adjusted gross margin, adjusted EBITDA and adjusted EBITDA margin. Reconciliation of these non-GAAP measures to the most comparable GAAP measures are included in the earnings release furnished to the SEC and available on our website.
I will now turn the call over to Andrew Stanleick, President and CEO of The Beauty Health Company.
Andrew Stanleick
Thank you, Eduardo. Good afternoon, everyone, and thank you for joining our first quarter earnings call. I'm excited to walk you through our outstanding performance in the first quarter and update you on the progress we are making on the strategic masterplan that I presented last quarter.
Before turning to those topics, I want to begin by thanking the global Beauty Health team and community for their hard work, passion, and commitment. As I enter my fourth month as CEO, I've had the privilege of meeting many of our talented employees and providers throughout the world. You have extended such a warm welcome to me, and you all make Beauty Health, the incredible company and community it is. With your dedication and support, we saw strong growth in the first quarter and continued to deliver against our strategic initiatives. Having partnered closely with Brent these past few months, we are very proud of the team's achievements and remain as confident as ever about the future as we carry this momentum forward.